March 16, 2020 / 12:28 PM / 22 days ago

BRIEF-Beyond Air Submits Investigational Device Exemption To The United States FDA For The Treatment Of COVID-19 Patients

March 16 (Reuters) - Beyond Air Inc:

* BEYOND AIR SUBMITS INVESTIGATIONAL DEVICE EXEMPTION (IDE) TO THE UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA) FOR THE TREATMENT OF COVID-19 PATIENTS

* BEYOND AIR INC - LUNGFIT BRO SYSTEM TO BE USED IN PROPOSED STUDY TO TREAT COVID-19 PATIENTS

* BEYOND AIR INC - GRANT APPLICATIONS HAVE BEEN SUBMITTED TO BIOMEDICAL ADVANCE RESEARCH AND DEVELOPMENT AUTHORITY (BARDA), A DIVISION OF HEALTH AND HHS

* BEYOND AIR - SECOND TRIAL DESIGN BEING VETTED TO INVESTIGATE USE IN PATIENTS EXPOSED TO SEVERE ACUTE RESPIRATORY SYNDROME 2 (SARS-COV-2), BUT NOT INFECTED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below